Cynthia Collins

Cynthia Collins has an estimated net worth of $3.19 Million. This is based on reported shares across multiple companies, which include Editas Medicine, Inc., Poseida Therapeutics, Inc., DermTech, Inc., Certara, Inc., BECKMAN COULTER INC, GENVEC INC, MAXCYTE, INC., and CODEXIS, INC..

2009 was Cynthia Collins's most active year for acquiring shares with 14 total transactions. Cynthia Collins's most active month to acquire stocks was the month of April. 2011 was Cynthia Collins's most active year for disposing of shares, totalling 12 transactions. Cynthia Collins's most active month to dispose stocks was the month of December. 2010 saw Cynthia Collins paying a total of $7,741.34 for 15,396.93 shares, this is the most they've acquired in one year. In 2011 Cynthia Collins cashed out on 92,930.091 shares for a total of $3,446,087.30, their largest year based on trade value.